Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.
Ther Adv Med Oncol
; 14: 17588359221099401, 2022.
Article
in En
| MEDLINE
| ID: mdl-35646162
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ther Adv Med Oncol
Year:
2022
Document type:
Article
Country of publication:
Reino Unido